Ciprofloxacin

Generic name: Pronounced as (sip roe flox' a sin)
Brand names
  • Cipro® Oral Suspension
  • Cipro® Tablets
  • Cipro® XR Extended-release Tablets
  • Proquin® XR Extended-release Tablets
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 12/15/2021

Taking ciprofloxacin increases the risk that you will develop tendinitis (swelling of a fibrous tissue that connects a bone to a muscle) or have a tendon rupture (tearing of a fibrous tissue that connects a bone to a muscle) during your treatment or for up to several months afterward. These problems may affect tendons in your shoulder, your hand, the back of your ankle, or in other parts of your body. Tendinitis or tendon rupture may happen to people of any age, but the risk is highest in people over 60 years of age. Tell your doctor if you have or have ever had a kidney, heart, or lung transplant; kidney disease; a joint or tendon disorder such as rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function); or if you participate in regular physical activity. Tell your doctor and pharmacist if you are taking oral or injectable steroids such as dexamethasone, methylprednisolone (Medrol), or prednisone (Rayos). If you experience any of the following symptoms of tendinitis, stop taking ciprofloxacin, rest, and call your doctor immediately: pain, swelling, tenderness, stiffness, or difficulty in moving a muscle. If you experience any of the following symptoms of tendon rupture, stop taking ciprofloxacin and get emergency medical treatment: hearing or feeling a snap or pop in a tendon area, bruising after an injury to a tendon area, or inability to move or to bear weight on an affected area.

Taking ciprofloxacin may cause changes in sensation and nerve damage that may not go away even after you stop taking ciprofloxacin. This damage may occur soon after you begin taking ciprofloxacin. Tell your doctor if you have ever had peripheral neuropathy (a type of nerve damage that causes tingling, numbness, and pain in the hands and feet). If you experience any of the following symptoms, stop taking ciprofloxacin and call your doctor immediately: numbness, tingling, pain, burning, or weakness in the arms or legs; or a change in your ability to feel light touch, vibrations, pain, heat, or cold.

Taking ciprofloxacin may affect your brain or nervous system and cause serious side effects. This can occur after the first dose of ciprofloxacin. Tell your doctor if you have or have ever had seizures, epilepsy, cerebral arteriosclerosis (narrowing of blood vessels in or near the brain that can lead to stroke or ministroke), stroke, changed brain structure, or kidney disease. If you experience any of the following symptoms, stop taking ciprofloxacin and call your doctor immediately: seizures; tremors; dizziness; lightheadedness; headaches that won't go away (with or without blurred vision); difficulty falling asleep or staying asleep; nightmares; not trusting others or feeling that others want to hurt you; hallucinations (seeing things or hearing voices that do not exist); thoughts or actions towards hurting or killing yourself; feeling restless, anxious, nervous, depressed, memory changes, or confused, or other changes in your mood or behavior.

Taking ciprofloxacin may worsen muscle weakness in people with myasthenia gravis (a disorder of the nervous system that causes muscle weakness) and cause severe difficulty breathing or death. Tell your doctor if you have myasthenia gravis. Your doctor may tell you not to take ciprofloxacin. If you have myasthenia gravis and your doctor tells you that you should take ciprofloxacin, call your doctor immediately if you experience muscle weakness or difficulty breathing during your treatment.

Talk to your doctor about the risks of taking ciprofloxacin.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with ciprofloxacin. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs) or the manufacturer's website to obtain the Medication Guide.

Ciprofloxacin is used to treat or prevent certain infections caused by bacteria such as pneumonia; gonorrhea (a sexually transmitted disease); typhoid fever (a serious infection that is common in developing countries); infectious diarrhea (infections that cause severe diarrhea); and infections of the skin, bone, joint, abdomen (stomach area), and prostate (male reproductive gland), Ciprofloxacin is also used to treat or prevent plague (a serious infection that may be spread on purpose as part of a bioterror attack) and inhalation anthrax (a serious infection that may be spread by anthrax germs in the air on purpose as part of a bioterror attack). Ciprofloxacin may also be used to treat bronchitis, sinus infections, or urinary tract infections but should not be used for bronchitis and sinus infections, or certain types of urinary tract infections if there are other treatment options. Ciprofloxacin extended-release (long-acting) tablets are used to treat kidney and urinary tract infections; however, some types of urinary tract infections should only be treated with ciprofloxacin extended release tablets if no other treatment options are available. Ciprofloxacin is in a class of antibiotics called fluoroquinolones. It works by killing bacteria that cause infections.

Antibiotics such as ciprofloxacin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.

Ciprofloxacin comes as a tablet, a suspension (liquid), and an extended-release tablet to take by mouth with or without food. The tablets and suspension are usually taken twice a day, and the extended-release tablets are usually taken once a day. When used to treat gonorrhea, the tablets and suspension may be given as a single dose. Take ciprofloxacin at around the same time(s) every day. The length of your treatment depends on the type of infection you have. Your doctor will tell you how long to take ciprofloxacin. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take ciprofloxacin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

One type of ciprofloxacin cannot be substituted for another. Be sure that you receive only the type of ciprofloxacin that was prescribed by your doctor. Ask your pharmacist if you have any questions about the type of ciprofloxacin you were given.

Do not take ciprofloxacin with dairy products or calcium-fortified juices alone. However, you may take ciprofloxacin with a meal that includes these foods or drinks.

Swallow the tablets whole; do not crush, or chew them. If you doctor tells you to to split the 250-mg or 500-mg tablet, it may be broken in half along the scored line. Swallow the extended-release tablets whole; do not split, crush, or chew them. If you cannot swallow tablets or extended-release tablets whole, tell your doctor.

If you are taking the suspension, shake the bottle very well for 15 seconds before each use to mix the medication evenly. Swallow the correct dose without chewing the granules in the suspension. Close the bottle completely after each use. Do not give the suspension to a patient through a feeding tube.

You should begin feeling better during the first few days of your treatment with ciprofloxacin. If your symptoms do not improve or if they get worse, call your doctor. If you are being treated for a urinary tract infection, call your doctor if you develop fever or back pain during or after your treatment. These symptoms may be signs that your infection is worsening.

Take ciprofloxacin until you finish the prescription, even if you feel better. Do not stop taking ciprofloxacin without talking to your doctor unless you experience certain serious side effects listed in the IMPORTANT WARNING and SIDE EFFECTS sections If you stop taking ciprofloxacin too soon or if you skip doses, your infection may not be completely treated and the bacteria may become resistant to antibiotics.

In the event of biological warfare, ciprofloxacin may be used to treat and prevent dangerous illnesses that are deliberately spread such as tularemia and anthrax of the skin or mouth. Ciprofloxacin is also sometimes used to treat cat scratch disease (an infection that may develop after a person is bitten or scratched by a cat), Legionnaires' disease (type of lung infection), chancroid (genital sores caused by bacteria), granuloma inguinale (donovanosis; a sexually transmitted disease), and infections of the outer ear that spread to the bones of the face. Ciprofloxacin may also be used to help treat tuberculosis and Crohn's disease (condition in which the immune system attacks the lining of the digestive tract causing pain, diarrhea, weight loss, and fever). Ciprofloxacin is also sometimes used to prevent traveler's diarrhea in certain patients and to prevent infections in patients who have fever and are at high risk for infection because they have very few white blood cells, people who are having certain types of surgery, and those people in close contact with someone who is sick with meningitis. Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking ciprofloxacin,

  • tell your doctor and pharmacist if you are allergic or have had a severe reaction to ciprofloxacin. any other quinolone or fluoroquinolone antibiotic such as delafloxacin (Baxdela), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), and ofloxacin; any other medications, or if you are allergic to any of the ingredients in ciprofloxacin tablets or suspension. Ask your doctor or pharmacist for a list of the ingredients.

  • tell your doctor if you are taking tizanidine (Zanaflex). Your doctor will probably tell you not to take ciprofloxacin while you are taking this medication.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); certain antidepressants; antipsychotics (medications to treat mental illness) such as clozapine (Clozaril, Fazaclo, Versacloz) and olanzapine (Zyprexa, in Symbax); azithromycin (Zithromax, Zmax); caffeine or medications that contain caffeine (Excedrin, NoDoz, Vivarin, others); clarithromycin (Biaxin, in Prevpac); cyclosporine (Gengraf, Neoral, Sandimmune); diuretics ('water pills'); duloxetine (Cymbalta); erythromycin (E.E.S., Eryc, Eryped, others); insulin or other medications to treat diabetes such as chlorpropamide, glimepiride (Amaryl, in Duetact), glipizide (Glucotrol), glyburide (DiaBeta), tolazamide, and tolbutamide; certain medications for irregular heartbeat such as amiodarone (Nexterone, Pacerone), disopyramide (Norpace), procainamide, quinidine (in Nuedexta), and sotalol (Betapace, Betapace AF, Sorine, Sotylize); methotrexate (Otrexup, Rasuvo, Trexall); certain nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin, others) and naproxen (Aleve, Naprosyn, others); pentoxifylline (Pentoxil); phenytoin (Dilantin, Phenytek); probenecid (Probalan, in Col-Probenecid); ropinirole (Requip); sildenafil (Revatio, Viagra); theophylline (Elixophyllin, Theo-24, Uniphyl, others); tizanidine (Zanaflex); or zolpidem (Ambien, Edluar, Intermezzo, Zolpimist). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with ciprofloxacin, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • if you are taking antacids containing calcium, aluminum hydroxide or magnesium hydroxide (Maalox, Mylanta, Tums, others); or certain medications such as didanosine (Videx) solution; calcium, iron, or zinc supplements; phosphate binders such as sevelamer (Renagel, Renvela) or lanthanum carbonate (Fosrenol); or sucralfate (Carafate), take ciprofloxacin at least 2 hours before or 6 hours after you take these medications.

  • tell your doctor if you or anyone in your family has or has ever had a prolonged QT interval (a rare heart problem that may cause irregular heartbeat, fainting, or sudden death). Also, tell your doctor if you have or have ever had an irregular or slow heartbeat, heart failure (condition in which the heart is unable to pump enough blood to the other parts of the body), a heart attack, an aortic aneurysm (swelling of the large artery that carries blood from the heart to the body), high blood pressure, peripheral vascular disease (poor circulation in the blood vessels), Marfan syndrome (a genetic condition that can affect the heart, eyes, blood vessels and bones), Ehlers-Danlos syndrome (a genetic condition that can affect skin, joints, or blood vessels), or have a low level of potassium or magnesium in your blood. Also tell your doctor if you have or have ever had diabetes or problems with low blood sugar or liver disease.

  • tell your doctor if you are pregnant or plan to become pregnant. If you become pregnant while taking ciprofloxacin, call your doctor.

  • tell your doctor if you are breastfeeding. You should not breastfeed while you are taking ciprofloxacin and for at least 2 days after your final dose.

  • do not drive a car, operate machinery or participate in activities requiring alertness or coordination until you know how this medication affects you.

  • plan to avoid unnecessary or prolonged exposure to sunlight or ultraviolet light (tanning beds and sunlamps) and to wear protective clothing, sunglasses, and sunscreen. Ciprofloxacin may make your skin sensitive to sunlight or ultraviolet light. If your skin becomes reddened, swollen, or blistered, like a bad sunburn, call your doctor.

Do not drink or eat a lot of caffeine-containing products such as coffee, tea, energy drinks, cola, or chocolate. Ciprofloxacin may increase nervousness, sleeplessness, heart pounding, and anxiety caused by caffeine.

Make sure you drink plenty of water or other fluids every day while you are taking ciprofloxacin.

If you miss a dose of ciprofloxacin tablets or suspension and it is 6 hours or more before the next dose, take the missed dose as soon as you remember it and then take the next dose at the scheduled time. However, if you miss a dose of ciprofloxacin tablets or suspension and it is less than 6 hours before the next dose, skip the missed dose and continue your regular dosing schedule.

If you miss a dose of the extended-release tablet and it is 8 hours or more before the next dose, take the dose as soon as you remember it and then take the next dose at the scheduled time. However, if you miss a dose of ciprofloxacin extended-release tablets and it is less than 8 hours before the next dose, skip the missed dose and continue your regular dosing schedule.

Do not take a double dose to make up for a missed one. Do not take more than two doses of the tablets or suspension or more than one dose of the extended-release tablets in one day.

  • Ciprofloxacin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • stomach pain

    • heartburn

    • diarrhea

    • vaginal itching and/or discharge

    • pale skin

    • unusual tiredness

    • sleepiness

  • If you experience any of the following symptoms, or those listed in the IMPORTANT WARNING section, stop taking ciprofloxacin and call your doctor immediately or get emergency medical help:

    • severe diarrhea (watery or bloody stools) that may occur with or without fever and stomach cramps (may occur up to 2 months or more after your treatment)

    • rash

    • hives

    • itching

    • peeling or blistering of the skin

    • fever

    • swelling of the eyes, face, mouth, lips, tongue, throat, hands, feet, ankles or lower legs

    • hoarseness or throat tightness

    • difficulty breathing or swallowing

    • ongoing or worsening cough

    • yellowing of the skin or eyes; pale skin; dark urine; or light colored stool

    • extreme thirst or hunger; pale skin; feeling shaky or trembling; fast or fluttering heartbeat; sweating; frequent urination; trembling; blurred vision; or unusual anxiety

    • fainting or loss of consciousness

    • decreased urination

    • sudden pain in the chest, stomach, or back

  • Ciprofloxacin may cause problems with bones, joints, and tissues around joints in children. Ciprofloxacin should not normally be given to children younger than 18 years of age unless they have certain serious infections that cannot be treated with other antibiotics or they have been exposed to plague or anthrax in the air. If your doctor prescribes ciprofloxacin for your child, be sure to tell the doctor if your child has or has ever had joint-related problems. Call your doctor if your child develops joint problems such as pain or swelling while taking ciprofloxacin or after treatment with ciprofloxacin.

  • Talk to your doctor about the risks of taking ciprofloxacin or giving ciprofloxacin to your child.

  • Ciprofloxacin may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store the tablets and extended-release tablets at room temperature and away from excess heat and moisture (not in the bathroom). Store the suspension in the refrigerator or at room temperature, closed tightly, for up to 14 days. Do not freeze ciprofloxacin suspension. Discard any suspension that is left over after 14 days.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to ciprofloxacin. If you have diabetes, your doctor may ask you to check your blood sugar more often while taking ciprofloxacin.

Do not let anyone else take your medication. Your prescription is probably not refillable. If you still have symptoms of infection after you finish taking ciprofloxacin, call your doctor.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Ciprofloxacin.
Repaglinide Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Ciprofloxacin.
Montelukast Montelukast The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Ciprofloxacin.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ciprofloxacin.
Leflunomide Leflunomide The metabolism of Leflunomide can be decreased when combined with Ciprofloxacin.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Ciprofloxacin.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Ciprofloxacin.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Dolasetron.
Alendronate Alendronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Alendronic acid.
Aminophylline Aminophylline The serum concentration of Aminophylline can be increased when it is combined with Ciprofloxacin.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Anagrelide.
Calcium Carbonate Calcium Carbonate Calcium carbonate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Candesartan Candesartan The risk or severity of hyperkalemia can be increased when Candesartan is combined with Ciprofloxacin.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Ciprofloxacin.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Ciprofloxacin.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Erythromycin can be decreased when combined with Ciprofloxacin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Conjugated estrogens can be decreased when combined with Ciprofloxacin.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Ciprofloxacin.
Guanfacine Guanfacine Ciprofloxacin may decrease the excretion rate of Guanfacine which could result in a higher serum level.
Magnesium Gluconate Magnesium Gluconate Magnesium gluconate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide Magnesium Hydroxide Magnesium hydroxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide Magnesium Oxide Magnesium oxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Ciprofloxacin.
Mycophenolate Mycophenolate Ciprofloxacin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Nafarelin Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Nafarelin.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Acebutolol.
Potassium Potassium Potassium may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone The risk or severity of tendinopathy can be increased when Prednisone is combined with Ciprofloxacin.
Ranitidine Ranitidine The metabolism of Ranitidine can be decreased when combined with Ciprofloxacin.
Reserpine Reserpine Reserpine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Rizatriptan Rizatriptan Ciprofloxacin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Ciprofloxacin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Ciprofloxacin.
Tizanidine Tizanidine The risk or severity of hypotension can be increased when Ciprofloxacin is combined with Tizanidine.
Triamcinolone Triamcinolone The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Triamcinolone.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Ciprofloxacin.
Ampicillin Injection Ampicillin Injection The serum concentration of Ciprofloxacin can be increased when it is combined with Ampicillin.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Ciprofloxacin.
Fluconazole Injection Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Ciprofloxacin.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Ciprofloxacin.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection The excretion of Levofloxacin can be decreased when combined with Ciprofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Ciprofloxacin.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Methylprednisolone.
Metoclopramide Injection Metoclopramide Injection The metabolism of Ciprofloxacin can be decreased when combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Ciprofloxacin.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Ciprofloxacin may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ciprofloxacin.
Altretamine Altretamine Amphetamine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Cyclosporine Cyclosporine Cyclosporine may increase the nephrotoxic activities of Ciprofloxacin.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Ondansetron.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Granisetron.
Torsemide Torsemide Torasemide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine The metabolism of Olanzapine can be decreased when combined with Ciprofloxacin.
Alosetron Alosetron The metabolism of Alosetron can be decreased when combined with Ciprofloxacin.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Ciprofloxacin.
Eprosartan Eprosartan The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Ciprofloxacin.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Ciprofloxacin.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Risedronate Risedronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Risedronic acid.
Sevelamer Sevelamer Sevelamer can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan Telmisartan The risk or severity of hyperkalemia can be increased when Telmisartan is combined with Ciprofloxacin.
Temozolomide Temozolomide Ciprofloxacin may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon The metabolism of Zaleplon can be decreased when combined with Ciprofloxacin.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Desloratadine.
Trimipramine Trimipramine The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Ciprofloxacin.
Perindopril Perindopril The risk or severity of hyperkalemia can be increased when Perindopril is combined with Ciprofloxacin.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Ciprofloxacin.
Dutasteride Dutasteride The metabolism of Dutasteride can be decreased when combined with Ciprofloxacin.
Eplerenone Eplerenone The metabolism of Eplerenone can be decreased when combined with Ciprofloxacin.
Escitalopram Escitalopram The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Escitalopram.
Olmesartan Olmesartan The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Ciprofloxacin.
Zonisamide Zonisamide The metabolism of Zonisamide can be decreased when combined with Ciprofloxacin.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Ciprofloxacin.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Ciprofloxacin.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Almotriptan Almotriptan Ciprofloxacin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Ciprofloxacin.
Rosuvastatin Rosuvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Rosuvastatin.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Ciprofloxacin.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Ciprofloxacin.
Aprepitant Aprepitant The metabolism of Aprepitant can be decreased when combined with Ciprofloxacin.
Emtricitabine Emtricitabine The excretion of Emtricitabine can be decreased when combined with Ciprofloxacin.
Memantine Memantine Ciprofloxacin may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil Tadalafil The metabolism of Tadalafil can be decreased when combined with Ciprofloxacin.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Ciprofloxacin.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Gemifloxacin.
Progesterone Progesterone The metabolism of Progesterone can be decreased when combined with Ciprofloxacin.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ciprofloxacin.
Infliximab Injection Infliximab Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Ciprofloxacin.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Ciprofloxacin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Ciprofloxacin.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Ciprofloxacin.
Tinidazole Tinidazole Ciprofloxacin may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Ciprofloxacin.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Erlotinib Erlotinib The serum concentration of Erlotinib can be increased when it is combined with Ciprofloxacin.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Ciprofloxacin.
Ganciclovir Ganciclovir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Ganciclovir.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be increased when used in combination with Ciprofloxacin.
Ribavirin Ribavirin Ciprofloxacin may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Ciprofloxacin.
Valganciclovir Valganciclovir Ciprofloxacin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Ciprofloxacin.
Adefovir Adefovir Adefovir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Entecavir Entecavir The metabolism of Entecavir can be decreased when combined with Ciprofloxacin.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Ciprofloxacin.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Ciprofloxacin.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Ciprofloxacin.
Ramelteon Ramelteon The serum concentration of Ramelteon can be increased when it is combined with Ciprofloxacin.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Ciprofloxacin.
Pregabalin Pregabalin The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ciprofloxacin.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Felbamate is combined with Ciprofloxacin.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be increased when used in combination with Ciprofloxacin.
Ranolazine Ranolazine The metabolism of Ciprofloxacin can be decreased when combined with Ranolazine.
Rasagiline Rasagiline The serum concentration of Rasagiline can be increased when it is combined with Ciprofloxacin.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Ciprofloxacin.
Sitagliptin Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Ciprofloxacin.
Varenicline Varenicline Ciprofloxacin may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib Gefitinib The metabolism of Gefitinib can be decreased when combined with Ciprofloxacin.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ciprofloxacin.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Bortezomib can be decreased when combined with Ciprofloxacin.
Clofarabine Injection Clofarabine Injection Ciprofloxacin may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Ciprofloxacin.
Lubiprostone Lubiprostone Ciprofloxacin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Ciprofloxacin.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ciprofloxacin.
Primaquine Primaquine The metabolism of Primaquine can be decreased when combined with Ciprofloxacin.
Pemetrexed Injection Pemetrexed Injection The metabolism of Pemetrexed can be decreased when combined with Ciprofloxacin.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Dimenhydrinate.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Ciprofloxacin.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ciprofloxacin.
Sorafenib Sorafenib The metabolism of Sorafenib can be decreased when combined with Ciprofloxacin.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Ciprofloxacin.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Ciprofloxacin.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Ciprofloxacin.
Pegaptanib Injection Pegaptanib Injection Ciprofloxacin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Ciprofloxacin can be decreased when combined with Dasatinib.
Mexiletine Mexiletine The metabolism of Mexiletine can be decreased when combined with Ciprofloxacin.
Azacitidine Injection Azacitidine Injection Ciprofloxacin may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Ivermectin Ivermectin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Ivermectin.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Ciprofloxacin.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Ciprofloxacin.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Toremifene.
Raltegravir Raltegravir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Raltegravir.
Budesonide Budesonide The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Budesonide.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Doripenem Injection Doripenem Injection Ciprofloxacin may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine Ciprofloxacin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Ciprofloxacin.
Bendamustine Injection Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Ciprofloxacin.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Ciprofloxacin.
Certolizumab Injection Certolizumab Injection Ciprofloxacin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Ciprofloxacin.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Ciprofloxacin.
Daptomycin Injection Daptomycin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Ciprofloxacin.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Ciprofloxacin.
Methylnaltrexone Injection Methylnaltrexone Injection Ciprofloxacin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide Rufinamide The metabolism of Rufinamide can be decreased when combined with Ciprofloxacin.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Ciprofloxacin.
Naltrexone Injection Naltrexone Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Naltrexone.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Ciprofloxacin.
Milnacipran Milnacipran Ciprofloxacin may decrease the excretion rate of Milnacipran which could result in a higher serum level.
Plerixafor Injection Plerixafor Injection Ciprofloxacin may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Ciprofloxacin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Ciprofloxacin.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Ciprofloxacin.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Ciprofloxacin.
Prasugrel Prasugrel Ciprofloxacin may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Ciprofloxacin.
Everolimus Everolimus The metabolism of Ciprofloxacin can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Ciprofloxacin can be decreased when combined with Tolvaptan.
Dronedarone Dronedarone The metabolism of Ciprofloxacin can be decreased when combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection Ciprofloxacin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Ciprofloxacin.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Ciprofloxacin.
Topotecan Topotecan The excretion of Topotecan can be decreased when combined with Ciprofloxacin.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Ciprofloxacin.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Asenapine.
Pitavastatin Pitavastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Pitavastatin.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Ciprofloxacin.
Levonorgestrel Levonorgestrel The metabolism of Levonorgestrel can be decreased when combined with Ciprofloxacin.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Ciprofloxacin.
Dalfampridine Dalfampridine Ciprofloxacin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Ciprofloxacin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Ciprofloxacin.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Lurasidone Lurasidone The metabolism of Lurasidone can be decreased when combined with Ciprofloxacin.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Ciprofloxacin.
Ipilimumab Injection Ipilimumab Injection Ciprofloxacin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Ciprofloxacin.
Azilsartan Azilsartan The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Ciprofloxacin.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Ciprofloxacin.
Roflumilast Roflumilast The serum concentration of Roflumilast can be increased when it is combined with Ciprofloxacin.
Linagliptin Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Ciprofloxacin.
Rilpivirine Rilpivirine The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Ciprofloxacin.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Ciprofloxacin.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Ciprofloxacin.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Ciprofloxacin.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Ciprofloxacin.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Ciprofloxacin.
Vandetanib Vandetanib The metabolism of Vandetanib can be decreased when combined with Ciprofloxacin.
Clobazam Clobazam Clobazam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Vemurafenib Vemurafenib The metabolism of Vemurafenib can be decreased when combined with Ciprofloxacin.
Ivacaftor Ivacaftor The metabolism of Ciprofloxacin can be decreased when combined with Ivacaftor.
Deferiprone Deferiprone Ciprofloxacin may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Ciprofloxacin.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Ciprofloxacin.
Cabergoline Cabergoline The metabolism of Cabergoline can be decreased when combined with Ciprofloxacin.
Naloxone Injection Naloxone Injection Ciprofloxacin may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Ciprofloxacin.
Fondaparinux Injection Fondaparinux Injection Ciprofloxacin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
Iloprost Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Iloprost.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be decreased when combined with Ciprofloxacin.
Mirabegron Mirabegron The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Ciprofloxacin.
Regorafenib Regorafenib The metabolism of Regorafenib can be decreased when combined with Ciprofloxacin.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Ciprofloxacin.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of tendinopathy can be increased when Corticotropin is combined with Ciprofloxacin.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Ciprofloxacin.
Teduglutide Injection Teduglutide Injection Ciprofloxacin may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Bedaquiline.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Ciprofloxacin.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Ciprofloxacin.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Ciprofloxacin.
Pomalidomide Pomalidomide The serum concentration of Pomalidomide can be increased when it is combined with Ciprofloxacin.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Ciprofloxacin.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Ciprofloxacin.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Ciprofloxacin.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The metabolism of Ciprofloxacin can be decreased when combined with Dabrafenib.
Trametinib Trametinib Ciprofloxacin may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran Ciprofloxacin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Ciprofloxacin.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Ciprofloxacin.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Ciprofloxacin.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Ciprofloxacin.
Avanafil Avanafil The metabolism of Avanafil can be decreased when combined with Ciprofloxacin.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Sofosbuvir Sofosbuvir Ciprofloxacin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Ciprofloxacin.
Iron Sucrose Injection Iron Sucrose Injection Iron sucrose can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Apremilast Apremilast The metabolism of Apremilast can be decreased when combined with Ciprofloxacin.
Ferumoxytol Injection Ferumoxytol Injection Ferumoxytol can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Droxidopa Droxidopa Ciprofloxacin may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Ciprofloxacin.
Sodium Ferric Gluconate Injection Sodium Ferric Gluconate Injection Sodium ferric gluconate complex can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Ciprofloxacin.
Iron Dextran Injection Iron Dextran Injection Iron Dextran can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric Carboxymaltose Injection Ferric Carboxymaltose Injection Ferric carboxymaltose can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Ciprofloxacin.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Ciprofloxacin.
Empagliflozin Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Ciprofloxacin.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Ciprofloxacin.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Ciprofloxacin.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Ciprofloxacin.
Edoxaban Edoxaban Ciprofloxacin may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Ciprofloxacin.
Methamphetamine Methamphetamine Ciprofloxacin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon The serum concentration of Tasimelteon can be increased when it is combined with Ciprofloxacin.
Pirfenidone Pirfenidone The serum concentration of Pirfenidone can be increased when it is combined with Ciprofloxacin.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Ciprofloxacin.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Risperidone is combined with Ciprofloxacin.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Ciprofloxacin.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be increased when used in combination with Ciprofloxacin.
Lenvatinib Lenvatinib The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Lenvatinib.
Naloxegol Naloxegol The metabolism of Naloxegol can be decreased when combined with Ciprofloxacin.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Ciprofloxacin.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Haloperidol.
Ivabradine Ivabradine The metabolism of Ciprofloxacin can be decreased when combined with Ivabradine.
Amiloride Amiloride Amiloride may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Ciprofloxacin may decrease the excretion rate of Macitentan which could result in a higher serum level.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Ciprofloxacin.
Flibanserin Flibanserin The metabolism of Ciprofloxacin can be decreased when combined with Flibanserin.
Prednisolone Prednisolone The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Prednisolone.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Ciprofloxacin.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Ciprofloxacin.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Ziprasidone.
Penicillin G Procaine Injection Penicillin G Procaine Injection The serum concentration of Procaine benzylpenicillin can be increased when it is combined with Ciprofloxacin.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be increased when used in combination with Ciprofloxacin.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Ciprofloxacin.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Ciprofloxacin.
Osimertinib Osimertinib The metabolism of Osimertinib can be decreased when combined with Ciprofloxacin.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Ciprofloxacin.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Ciprofloxacin.
Patiromer Patiromer Patiromer can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lesinurad Lesinurad Ciprofloxacin may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Ciprofloxacin.
Brivaracetam Injection Brivaracetam Injection Ciprofloxacin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Ciprofloxacin.
Cobicistat Cobicistat The metabolism of Cobicistat can be decreased when combined with Ciprofloxacin.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Ciprofloxacin.
Furosemide Injection Furosemide Injection Ciprofloxacin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Ciprofloxacin.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Ciprofloxacin.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Ribociclib.
Brigatinib Brigatinib The metabolism of Ciprofloxacin can be decreased when combined with Brigatinib.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Ciprofloxacin.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Ciprofloxacin.
Deflazacort Deflazacort The serum concentration of Ciprofloxacin can be increased when it is combined with Deflazacort.
Naldemedine Naldemedine Ciprofloxacin may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The metabolism of Midostaurin can be decreased when combined with Ciprofloxacin.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Ciprofloxacin.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Ciprofloxacin.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Ciprofloxacin.
Benznidazole Benznidazole Ciprofloxacin may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Ciprofloxacin.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ciprofloxacin.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Ciprofloxacin.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Ciprofloxacin.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Ciprofloxacin.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Ciprofloxacin.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Ciprofloxacin.
Apalutamide Apalutamide Ciprofloxacin may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Penicillamine Penicillamine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Penicillamine.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Ciprofloxacin.
Lofexidine Lofexidine The metabolism of Lofexidine can be decreased when combined with Ciprofloxacin.
Plazomicin Injection Plazomicin Injection Ciprofloxacin may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Ciprofloxacin.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Encorafenib.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Ciprofloxacin.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Ciprofloxacin.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Ciprofloxacin.
Tafenoquine Tafenoquine The excretion of Ciprofloxacin can be decreased when combined with Tafenoquine.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Ciprofloxacin.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Ciprofloxacin.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Ciprofloxacin.
Stiripentol Stiripentol The metabolism of Stiripentol can be decreased when combined with Ciprofloxacin.
Gilteritinib Gilteritinib The excretion of Ciprofloxacin can be decreased when combined with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Ciprofloxacin.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Ciprofloxacin.
Rifamycin Rifamycin The excretion of Ciprofloxacin can be decreased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Ciprofloxacin.
Magnesium Citrate Magnesium Citrate Magnesium citrate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Ciprofloxacin is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Acyclovir can be decreased when combined with Ciprofloxacin.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Ciprofloxacin.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Ciprofloxacin.
Cladribine Cladribine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Ciprofloxacin.
Solriamfetol Solriamfetol The excretion of Solriamfetol can be decreased when combined with Ciprofloxacin.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Ciprofloxacin.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Ciprofloxacin.
Pexidartinib Pexidartinib The metabolism of Ciprofloxacin can be decreased when combined with Pexidartinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Ciprofloxacin.
Pitolisant Pitolisant Pitolisant may increase the QTc-prolonging activities of Ciprofloxacin.
Pretomanid Pretomanid The serum concentration of Pretomanid can be increased when it is combined with Ciprofloxacin.
Fedratinib Fedratinib The excretion of Ciprofloxacin can be decreased when combined with Fedratinib.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Ciprofloxacin.
Phenytoin Injection Phenytoin Injection The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.
Fosphenytoin Injection Fosphenytoin Injection The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Ciprofloxacin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Ciprofloxacin.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Ciprofloxacin.
Lumateperone Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Ciprofloxacin.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Ciprofloxacin.
Calcium Acetate Calcium Acetate Calcium acetate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tazemetostat Tazemetostat The excretion of Ciprofloxacin can be decreased when combined with Tazemetostat.
Cenobamate Cenobamate The metabolism of Cenobamate can be decreased when combined with Ciprofloxacin.
Pemigatinib Pemigatinib The metabolism of Pemigatinib can be decreased when combined with Ciprofloxacin.
Selumetinib Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Ciprofloxacin.
Rimegepant Rimegepant The metabolism of Rimegepant can be decreased when combined with Ciprofloxacin.
Tucatinib Tucatinib The excretion of Ciprofloxacin can be decreased when combined with Tucatinib.
Remdesivir Injection Remdesivir Injection The excretion of Ciprofloxacin can be decreased when combined with Remdesivir.
Ripretinib Ripretinib The excretion of Ciprofloxacin can be decreased when combined with Ripretinib.
Selpercatinib Selpercatinib The serum concentration of Ciprofloxacin can be increased when it is combined with Selpercatinib.
Capmatinib Capmatinib The serum concentration of Capmatinib can be increased when it is combined with Ciprofloxacin.
Lemborexant Lemborexant The serum concentration of Lemborexant can be increased when it is combined with Ciprofloxacin.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Ciprofloxacin.
Lurbinectedin Injection Lurbinectedin Injection The serum concentration of Lurbinectedin can be increased when it is combined with Ciprofloxacin.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ciprofloxacin.
Pralsetinib Pralsetinib The excretion of Ciprofloxacin can be decreased when combined with Pralsetinib.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Ciprofloxacin.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine Ciprofloxacin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Theophylline Theophylline The serum concentration of Theophylline can be increased when it is combined with Ciprofloxacin.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Indomethacin Indomethacin Indomethacin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Ciprofloxacin.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Ciprofloxacin.
Isotretinoin Isotretinoin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Isotretinoin.
Sucralfate Sucralfate Sucralfate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Bicarbonate Sodium Bicarbonate Sodium bicarbonate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Metaxalone Metaxalone Ciprofloxacin may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.
Methsuximide Methsuximide The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Ciprofloxacin.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Ciprofloxacin.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Ciprofloxacin.
Oxazepam Oxazepam Ciprofloxacin may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Ciprofloxacin may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Ciprofloxacin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam The metabolism of Ciprofloxacin can be decreased when combined with Lorazepam.
Carmustine Carmustine The metabolism of Carmustine can be decreased when combined with Ciprofloxacin.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Ciprofloxacin.
Codeine Codeine Codeine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Bromocriptine Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Ciprofloxacin.
Phenelzine Phenelzine Ciprofloxacin may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Procarbazine Procarbazine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Procarbazine.
Tetracycline Tetracycline Ciprofloxacin may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Minocycline Minocycline The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Minocycline.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Ciprofloxacin.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Thioridazine.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Ciprofloxacin.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Ciprofloxacin.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Ciprofloxacin.
Oxycodone Oxycodone The metabolism of Oxycodone can be decreased when combined with Ciprofloxacin.
Methadone Methadone The metabolism of Methadone can be decreased when combined with Ciprofloxacin.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be decreased when combined with Ciprofloxacin.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Ciprofloxacin.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Ciprofloxacin.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Orphenadrine Orphenadrine The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Ciprofloxacin.
Perphenazine Perphenazine The metabolism of Perphenazine can be decreased when combined with Ciprofloxacin.
Azathioprine Azathioprine The metabolism of Azathioprine can be decreased when combined with Ciprofloxacin.
Phentermine Phentermine The metabolism of Phentermine can be decreased when combined with Ciprofloxacin.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Ciprofloxacin.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Hydrocortisone Hydrocortisone The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Hydrocortisone.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Ciprofloxacin.
Cytarabine Cytarabine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Cytarabine.
Phenazopyridine Phenazopyridine The bioavailability of Ciprofloxacin can be increased when combined with Phenazopyridine.
Carbamazepine Carbamazepine The serum concentration of Carbamazepine can be increased when it is combined with Ciprofloxacin.
Methyldopa Methyldopa The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Methyldopa.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Ciprofloxacin.
Hydralazine Hydralazine Ciprofloxacin may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cimetidine is combined with Ciprofloxacin.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Ciprofloxacin.
Clonazepam Clonazepam Ciprofloxacin may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Loperamide.
Promethazine Promethazine The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Promethazine.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin The therapeutic efficacy of Ciprofloxacin can be decreased when used in combination with Nitrofurantoin.
Digoxin Digoxin Ciprofloxacin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Ciprofloxacin.
Quinine Quinine The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Ciprofloxacin.
Triamterene Triamterene The metabolism of Triamterene can be decreased when combined with Ciprofloxacin.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Ciprofloxacin.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Ciprofloxacin.
Secobarbital Secobarbital Secobarbital may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Desipramine Desipramine The risk or severity of QTc prolongation can be increased when Desipramine is combined with Ciprofloxacin.
Amitriptyline Amitriptyline Ciprofloxacin may increase the QTc-prolonging activities of Amitriptyline.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Ciprofloxacin.
Probenecid Probenecid Probenecid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Ciprofloxacin.
Procainamide Procainamide The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Procainamide.
Isoniazid Isoniazid The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Isoniazid.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Disopyramide.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Ciprofloxacin can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital Butabarbital may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Levothyroxine Levothyroxine Ciprofloxacin can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Methimazole Methimazole Ciprofloxacin may decrease the excretion rate of Methimazole which could result in a higher serum level.
Propylthiouracil Propylthiouracil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Propylthiouracil.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Ciprofloxacin.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Ciprofloxacin.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Ciprofloxacin.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Ciprofloxacin.
Cyclobenzaprine Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Ciprofloxacin.
Niacin Niacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Niacin.
Baclofen Baclofen The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ciprofloxacin.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Ciprofloxacin.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Ciprofloxacin.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Ciprofloxacin.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Ciprofloxacin.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Ciprofloxacin.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Ciprofloxacin.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Ciprofloxacin.
Nortriptyline Nortriptyline The metabolism of Ciprofloxacin can be decreased when combined with Nortriptyline.
Spironolactone Spironolactone Spironolactone may increase the arrhythmogenic activities of Ciprofloxacin.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Mercaptopurine Mercaptopurine The serum concentration of Mercaptopurine can be increased when it is combined with Ciprofloxacin.
Phytonadione Phytonadione Ciprofloxacin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Nadolol Nadolol The excretion of Nadolol can be decreased when combined with Ciprofloxacin.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ciprofloxacin.
Flavoxate Flavoxate Ciprofloxacin may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Ciprofloxacin.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Ciprofloxacin.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Dacarbazine Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Ciprofloxacin.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Ciprofloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Iron Supplements Iron Supplements Iron can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Ketoconazole Ketoconazole The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Ciprofloxacin.
Pyrantel Pyrantel Ciprofloxacin may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Ciprofloxacin.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be decreased when combined with Ciprofloxacin.
Captopril Captopril The risk or severity of hyperkalemia can be increased when Captopril is combined with Ciprofloxacin.
Vinblastine Vinblastine The metabolism of Vinblastine can be decreased when combined with Ciprofloxacin.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Metoprolol Metoprolol The metabolism of Ciprofloxacin can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Ciprofloxacin.
Thiothixene Thiothixene The metabolism of Thiothixene can be decreased when combined with Ciprofloxacin.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Ciprofloxacin.
Temazepam Temazepam Temazepam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Triazolam Triazolam The metabolism of Triazolam can be decreased when combined with Ciprofloxacin.
Dicyclomine Dicyclomine Ciprofloxacin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ciprofloxacin.
Propantheline Propantheline Ciprofloxacin may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Ciprofloxacin.
Diltiazem Diltiazem The metabolism of Diltiazem can be decreased when combined with Ciprofloxacin.
Nifedipine Nifedipine The metabolism of Nifedipine can be decreased when combined with Ciprofloxacin.
Timolol Timolol The risk or severity of QTc prolongation can be increased when Timolol is combined with Ciprofloxacin.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Ciprofloxacin.
Pindolol Pindolol Ciprofloxacin may decrease the excretion rate of Pindolol which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection Ciprofloxacin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Bumetanide Bumetanide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Bumetanide.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Ciprofloxacin.
Glyburide Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Ciprofloxacin.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Ciprofloxacin.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Indapamide is combined with Ciprofloxacin.
Amoxicillin Amoxicillin The serum concentration of Amoxicillin can be increased when it is combined with Ciprofloxacin.
Dicloxacillin Dicloxacillin The serum concentration of Ciprofloxacin can be increased when it is combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The serum concentration of Ciprofloxacin can be increased when it is combined with Nafcillin.
Oxacillin Injection Oxacillin Injection The serum concentration of Oxacillin can be increased when it is combined with Ciprofloxacin.
Pentoxifylline Pentoxifylline The serum concentration of Pentoxifylline can be increased when it is combined with Ciprofloxacin.
Pentamidine Injection Pentamidine Injection The therapeutic efficacy of Pentamidine can be increased when used in combination with Ciprofloxacin.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Labetalol Labetalol Ciprofloxacin may decrease the excretion rate of Labetalol which could result in a higher serum level.
Auranofin Auranofin Ciprofloxacin may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Ciprofloxacin.
Gemfibrozil Gemfibrozil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Gemfibrozil.
Guanabenz Guanabenz The metabolism of Guanabenz can be decreased when combined with Ciprofloxacin.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Ciprofloxacin.
Enalapril Enalapril The risk or severity of hyperkalemia can be increased when Enalapril is combined with Ciprofloxacin.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Amiodarone Amiodarone The metabolism of Ciprofloxacin can be decreased when combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Buspirone Buspirone The metabolism of Buspirone can be decreased when combined with Ciprofloxacin.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Diclofenac Diclofenac The metabolism of Diclofenac can be decreased when combined with Ciprofloxacin.
Fluoxetine Fluoxetine The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Ciprofloxacin.
Clozapine Clozapine The serum concentration of Clozapine can be increased when it is combined with Ciprofloxacin.
Estazolam Estazolam Ciprofloxacin may decrease the excretion rate of Estazolam which could result in a higher serum level.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Ofloxacin.
Didanosine Didanosine Didanosine can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pentostatin Injection Pentostatin Injection Ciprofloxacin may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Clarithromycin Clarithromycin The metabolism of Clarithromycin can be decreased when combined with Ciprofloxacin.
Benazepril Benazepril The risk or severity of hyperkalemia can be increased when Benazepril is combined with Ciprofloxacin.
Etodolac Etodolac Etodolac may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Felodipine Felodipine The metabolism of Felodipine can be decreased when combined with Ciprofloxacin.
Fosinopril Fosinopril The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Ciprofloxacin.
Nabumetone Nabumetone The metabolism of Nabumetone can be decreased when combined with Ciprofloxacin.
Pravastatin Pravastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Ciprofloxacin.
Quinapril Quinapril Quinapril can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ramipril Ramipril The risk or severity of hyperkalemia can be increased when Ramipril is combined with Ciprofloxacin.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Ciprofloxacin.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be decreased when combined with Ciprofloxacin.
Itraconazole Itraconazole The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Ciprofloxacin.
Lisinopril Lisinopril The risk or severity of hyperkalemia can be increased when Lisinopril is combined with Ciprofloxacin.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Sotalol Sotalol The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Sotalol.
Bisoprolol Bisoprolol Ciprofloxacin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Ciprofloxacin.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Ciprofloxacin.
Isradipine Isradipine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ciprofloxacin.
Cisapride Cisapride The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Cisapride.
Fluvastatin Fluvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Fluvastatin.
Venlafaxine Venlafaxine The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Ciprofloxacin.
Nizatidine Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Nizatidine.
Stavudine Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Stavudine.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Ciprofloxacin.
Fluvoxamine Fluvoxamine The metabolism of Fluvoxamine can be decreased when combined with Ciprofloxacin.
Nefazodone Nefazodone Ciprofloxacin may decrease the excretion rate of Nefazodone which could result in a higher serum level.
Lamotrigine Lamotrigine The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Ciprofloxacin.
Losartan Losartan The risk or severity of hyperkalemia can be increased when Losartan is combined with Ciprofloxacin.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Tramadol Tramadol The metabolism of Ciprofloxacin can be decreased when combined with Tramadol.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Ciprofloxacin.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Moexipril Moexipril The risk or severity of hyperkalemia can be increased when Moexipril is combined with Ciprofloxacin.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Ciprofloxacin.
Nicardipine Nicardipine The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Ciprofloxacin.
Bupropion Bupropion Ciprofloxacin may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine The metabolism of Ciprofloxacin can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Saquinavir can be decreased when combined with Ciprofloxacin.
Metformin Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Ciprofloxacin.
Nisoldipine Nisoldipine The metabolism of Nisoldipine can be decreased when combined with Ciprofloxacin.
Lamivudine Lamivudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Lamivudine.
Riluzole Riluzole The metabolism of Riluzole can be decreased when combined with Ciprofloxacin.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Ciprofloxacin.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Ciprofloxacin.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Indinavir Indinavir The metabolism of Indinavir can be decreased when combined with Ciprofloxacin.
Ritonavir Ritonavir The metabolism of Ritonavir can be decreased when combined with Ciprofloxacin.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Ciprofloxacin.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Meropenem Injection Meropenem Injection Ciprofloxacin may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Ciprofloxacin.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Ciprofloxacin.
Fosfomycin Fosfomycin Ciprofloxacin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Ciprofloxacin.
Trandolapril Trandolapril The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Ciprofloxacin.
Topiramate Topiramate Topiramate may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Ciprofloxacin.
Valsartan Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Ciprofloxacin.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ciprofloxacin.
Pramipexole Pramipexole Pramipexole may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Nelfinavir Nelfinavir The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Ciprofloxacin.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Ciprofloxacin.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Ciprofloxacin.
Nilutamide Nilutamide Ciprofloxacin may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide The metabolism of Flutamide can be decreased when combined with Ciprofloxacin.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Ciprofloxacin.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Ciprofloxacin.
Propafenone Propafenone The metabolism of Propafenone can be decreased when combined with Ciprofloxacin.
Letrozole Letrozole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Letrozole.
Irbesartan Irbesartan The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Ciprofloxacin.
Tamsulosin Tamsulosin Ciprofloxacin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Ciprofloxacin is combined with Ropinirole.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Ciprofloxacin.
Quetiapine Quetiapine The metabolism of Quetiapine can be decreased when combined with Ciprofloxacin.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Ciprofloxacin.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Ciprofloxacin.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Citalopram.
Capecitabine Capecitabine Ciprofloxacin may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz Efavirenz The metabolism of Efavirenz can be decreased when combined with Ciprofloxacin.
Abacavir Abacavir Ciprofloxacin may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Ciprofloxacin.
Pioglitazone Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Ciprofloxacin.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Rosiglitazone Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Ciprofloxacin.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Ciprofloxacin.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Aluminum Hydroxide Aluminum Hydroxide Aluminum hydroxide can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Nateglinide Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Ciprofloxacin.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ciprofloxacin.
Rabeprazole Rabeprazole Ciprofloxacin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Ciprofloxacin.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists